Mangrove Partners »

Dyne Therapeutics shares owned by Mangrove Partners

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Mangrove Partners from 13F filings

Historical chart of Mangrove Partners investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Mangrove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Mangrove Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $869k 48k 18.13

More positions owned by Mangrove Partners

Indivior Pharmaceuticals (INDV)
Atmus Filtration Technologies Ord (ATMU)
Grayscale Ethereum Staking Shs New (ETH)
Rex American Resources (REX)
PG&E Corporation (PCG)
Oneok (OKE)
Millicom Intl Cellular S A Com Stk (TIGO)
Enova Intl (ENVA)
Millrose Pptys Com Cl A (MRP)
Keurig Dr Pepper (KDP)
Union Pacific Corporation (UNP)
Bio Rad Labs Cl A (BIO)
Flywire Corporation Com Vtg (FLYW)
Genuine Parts Company (GPC)
Bill Com Holdings Ord (BILL)

View all positions for Mangrove Partners

Top funds holding Dyne Therapeutics

Henderson Group
BlackRock
Atlas Venture Life Science Advisors
FMR
Orbis Allan Gray
State Street Corporation
Vanguard Capital Management
Perceptive Advisors
Fcpm Iii Services B.v.
TCG Crossover Management
Vanguard Portfolio Management
Vestal Point Capital
Geode Capital Management
Armistice Capital
Frazier Life Sciences Management

View all funds holding Dyne Therapeutics